Steven A. Kriegsman, Director at RXI PHARMACEUTICALS CORP (RXII), sold 13,084 shares at $5.04 ($67K) on 2009-06-01, disclosed to the SEC on 2009-06-03.
Scheduled sale ($67k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.04 | 7,000 | $35K | 52.8% |
| 2 | $5.19 | 6,084 | $32K | 47.2% |
| Total | $5.11 avg | 13,084 | $67K | 100% |
| Filing → |
| CYTR | BUY | 2012-02-24 | $51K | — | Filing → |
| RXII | SELL | 2009-08-20 | $28K | — | Filing → |
| RXII | SELL | 2009-07-06 | $13K | — | Filing → |